companydata.dkcompanydata.dk

NORDIC BIOTECH K/S: Financial statements 2019

CVR: 26290724

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 12,997,000 compared with DKK -464,676,000 the year before. Equity in the 2019 report amounted to DKK 86,469,000. The solvency ratio was 99.8%.

Profit/Loss
DKK 12,997,000
Equity
DKK 86,469,000
Total Assets
DKK 86,604,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--13M86.5M0
2018---464.7M73.5M-
2017--149.6M538.1M-
2016---1.1B2.3B-
2015--317.4M3.4B-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

NORDIC BIOTECH K/S: The 2018 annual report is outMay 1, 2019

NORDIC BIOTECH K/S has published its annual report for 2018. The net result was DKK -464,676,000.

About NORDIC BIOTECH K/S

NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.

Source: annual report 2024, Danish Business Authority